As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...